✦ LIBER ✦

Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer

✍ Scribed by Vivek Roy; Edith A. Perez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN91 LONG TERM COST-EFFECTIVENESS OF DO

✍ D Jackson; JM Lee; J Adams; A Gordois 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Improvement in Disease-Free Survival wit

✍ Amy I. D'Orazio; Joyce O'Shaughnessy 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 96 KB

Doxorubicin and paclitaxel improve survi

✍ Heinz Ludwig 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Cost–effectiveness analysis of adjuvant

✍ Sang Gyu Lee; Young Geon Jee; Hyun Chul Chung; Sung-Bae Kim; Jungsil Ro; Young-H 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 231 KB

Quality of life and toxicity in breast c

✍ N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB